FDA Approved: OXLUMO — Original Application (Alnylam Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved OXLUMO (lumasiran) from Alnylam Pharmaceuticals for the treatment of primary hyperoxaluria type 1.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperoxaluria Type

Drugs mentioned

• Oxlumo (lumasiran)

Snippet

ORIG AP for OXLUMO (LUMASIRAN)